X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Making coupons count for patients with HIV

By Emilie Signora  |    August 8, 2022
Despite having insurance, too many patients with HIV face high out-of-pocket costs for brand medicines. This is largely driven by insurer-imposed barriers that shift the cost of life-saving care onto...   Read More

Patients win as West Virginia implements first-in-nation share the savings policy

By Reid Porter  |    July 8, 2022
West Virginia took a big step towards making insurance work like it should last week. As of July 1, thanks to bipartisan state legislation passed and signed by the Governor in 2021, insurers and...   Read More

3 things voters are concerned about when it comes to their health care coverage

By Cynthia Hicks  |    July 7, 2022
A recent Ipsos/PhRMA survey of more than 2,500 registered voters paints a clear picture of health care issues that keep them up at night: insurance coverage and out-of-pocket costs. Voters voice...   Read More

Copay assistance is a lifeline for patients. So why are insurers blocking it?

By Stephen J. Ubl  |    June 29, 2022
In today’s broken insurance system, patients too often pay more for a medicine than what their insurance company pays.   Read More

New poll shows voters sounding the alarm on health insurance companies and PBMs

By Cynthia Hicks  |    June 6, 2022
Many Americans battle with an illness every day, but unfortunately for some, their illness is not the only battle they face. A recent Morning Consult/PhRMA poll of 2,004 registered voters shows that...   Read More

In comments to federal agency, PhRMA warns of the growing influence of middlemen over patient access and out-of-pocket costs for prescription medicines

By Brian Newell  |    May 31, 2022
In comments submitted to the Federal Trade Commission (FTC), PhRMA urged the agency to examine how pharmacy benefit managers (PBMs) leverage their extraordinary power to maximize profits, often in...   Read More

Report finds PBMs are increasingly restricting patient access to medicines

By Brian Newell  |    May 25, 2022
More than 1,150 medicines were excluded from at least one of the three largest PBMs’ standard commercial formularies in 2022, according to a new report from Xcenda. The report is further evidence of...   Read More

ICYMI: PhRMA COO Lori Reilly spotlights efforts to improve health care in 2022 and beyond

By Emilie Signora  |    May 9, 2022
The COVID-19 pandemic has made clear how important a stable health care system is to the American people, both during times of crisis and beyond. Patients deserve sustainable, patient-centered...   Read More

Study finds insurance barriers disproportionately burden patients with chronic illness

By Cynthia Hicks  |    May 4, 2022
A recent Patient Experience Survey found that Americans with serious chronic conditions, including autoimmune diseases, mental health conditions and neurologic conditions were more likely than all...   Read More

5 public opinion polling trends to watch

By Tom Wilbur  |    April 22, 2022
Today, we’re taking a closer look at Americans’ leading concerns and what issues they want policymakers to prioritize.   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates